Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    March 2017
  1. ZUGAZAGOITIA J, Molina-Pinelo S, Lopez-Rios F, Paz-Ares L, et al
    Biological therapies in nonsmall cell lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    January 2017
  2. DE-TORRES JP, Sanchez-Salcedo P, Bastarrika G, Alcaide AB, et al
    Telomere length, COPD and emphysema as risk factors for lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  3. MCDONALD F, De Waele M, Hendriks LE, Faivre-Finn C, et al
    Management of stage I and II nonsmall cell lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    November 2016
  4. SHIN S, Park HY, Kim H, Kim HK, et al
    Joint effect of airflow limitation and emphysema on postoperative outcomes in early-stage nonsmall cell lung cancer.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01148-2016. doi: 10.1183/13993003.01148-2016.
    PubMed     Text format     Abstract available


  5. RUANO-RAVINA A, Torres-Duran M, Kelsey KT, Parente-Lamelas I, et al
    Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases.
    Eur Respir J. 2016;48:1462-1470.
    PubMed     Text format     Abstract available


    September 2016

  6. "Plasma pro-surfactant protein B and lung function decline in smokers." Janice M. Leung, John Mayo, Wan Tan, C. Martin Tammemagi, Geoffrey Liu, Stuart Peacock, Frances A. Shepherd, John Goffin, Glenwood Goss, Garth Nicholas, Alain Tremblay, Michael Jo
    Eur Respir J. 2016;48:962.
    PubMed     Text format    


  7. LEE SY, Kang HG, Choi JE, Jung DK, et al
    Polymorphisms in cancer-related pathway genes and lung cancer.
    Eur Respir J. 2016 Sep 1. pii: ERJ-02040-2015. doi: 10.1183/13993003.02040-2015.
    PubMed     Text format     Abstract available


    July 2016
  8. MAK KS, van Bommel AC, Stowell C, Abrahm JL, et al
    Defining a standard set of patient-centred outcomes for lung cancer.
    Eur Respir J. 2016 Jul 7. pii: ERJ-02049-2015. doi: 10.1183/13993003.02049-2015.
    PubMed     Text format     Abstract available


  9. CIHORIC N, Tsikkinis A, Filipovic N, Jeremic B, et al
    Treatment options for isolated locoregional recurrences of nonsmall cell lung cancer after surgery: yes, radiation therapy too!
    Eur Respir J. 2016;48:276-8.
    PubMed     Text format    


    June 2016
  10. FITENI F, Anota A, Bonnetain F, Oster JP, et al
    Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy.
    Eur Respir J. 2016 Jun 23. pii: ERJ-01695-2015. doi: 10.1183/13993003.01695-2015
    PubMed     Text format     Abstract available


    May 2016
  11. MALHOTRA J, Malvezzi M, Negri E, La Vecchia C, et al
    Risk factors for lung cancer worldwide.
    Eur Respir J. 2016 May 12. pii: ERJ-00359-2016. doi: 10.1183/13993003.00359-2016
    PubMed     Text format     Abstract available


  12. IRIE M, Nakanishi R, Yasuda M, Fujino Y, et al
    Risk factors for short-term outcomes after thoracoscopic lobectomy for lung cancer.
    Eur Respir J. 2016 May 12. pii: ERJ-01939-2015. doi: 10.1183/13993003.01939-2015
    PubMed     Text format     Abstract available


  13. REMON J, Bonastre J, Besse B
    The 5000% case: a glimpse into the financial issue of lung cancer treatment.
    Eur Respir J. 2016;47:1331-3.
    PubMed     Text format    


    April 2016

  14. "Lung cancer survival in Norway, 1997-2011: from nihilism to optimism." Yngvar Nilssen, Trond Eirik Strand, Lars Fjellbirkeland, Kristian Bartnes and Bjorn Moller. Eur Respir J 2016; 47: 275-287.
    Eur Respir J. 2016;47:1297.
    PubMed     Text format    


    March 2016
  15. CARBONNAUX M, Souquet PJ, Meert AP, Scherpereel A, et al
    Inequalities in lung cancer: a world of EGFR.
    Eur Respir J. 2016 Mar 30. pii: ERJ-01157-2015. doi: 10.1183/13993003.01157-2015
    PubMed     Text format     Abstract available


  16. PAGES PB, Cottenet J, Mariet AS, Bernard A, et al
    In-hospital mortality following lung cancer resection: nationwide administrative database.
    Eur Respir J. 2016 Mar 10. pii: ERJ-00052-2016. doi: 10.1183/13993003.00052-2016
    PubMed     Text format     Abstract available


  17. JANSSENS A, Teugels L, Kohl S, Michielsen T, et al
    Practical tools for implementing early palliative care in advanced lung cancer.
    Eur Respir J. 2016;47:1010-2.
    PubMed     Text format    


  18. TRAVIS WD, Brambilla E, Geisinger KR
    Histological grading in lung cancer: one system for all or separate systems for each histological type?
    Eur Respir J. 2016;47:720-3.
    PubMed     Text format    


    February 2016
  19. GUILLON A, Gueugnon F, Mavridis K, Dalloneau E, et al
    Interleukin-22 receptor is overexpressed in nonsmall cell lung cancer and portends a poor prognosis.
    Eur Respir J. 2016 Feb 4. pii: ERJ-01580-2015. doi: 10.1183/13993003.01580-2015.
    PubMed     Text format    


  20. SUBOTIC D, Van Schil P, Grigoriu B
    Optimising treatment for post-operative lung cancer recurrence.
    Eur Respir J. 2016;47:374-8.
    PubMed     Text format    


  21. PRICE LC, Wort SJ
    Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy.
    Eur Respir J. 2016;47:690-1.
    PubMed     Text format    


  22. MERAD M, Savale L, Antoun S, Vincent F, et al
    Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy?
    Eur Respir J. 2016;47:688-90.
    PubMed     Text format    


  23. DERKS JL, Hendriks LE, Buikhuisen WA, Groen HJ, et al
    Clinical features of large cell neuroendocrine carcinoma: a population-based overview.
    Eur Respir J. 2016;47:615-24.
    PubMed     Text format     Abstract available


  24. STEINFORT DP, Bonney A, See K, Irving LB, et al
    Sequential multimodality bronchoscopic investigation of peripheral pulmonary lesions.
    Eur Respir J. 2016;47:607-14.
    PubMed     Text format     Abstract available


    January 2016
  25. FAURE M
    Lung cancer in Europe: turning the spotlight on the biggest cancer killer.
    Eur Respir J. 2016;47:42-4.
    PubMed     Text format    


  26. PINETON DE CHAMBRUN M, Lemiale V, Azoulay E
    Lung positron emission tomography with FDG in patients with haematological malignancies and acute respiratory failure.
    Eur Respir J. 2016;47:324-7.
    PubMed     Text format    


    December 2015
  27. TORRES-DURAN M, Ruano-Ravina A, Kelsey KT, Parente-Lamelas I, et al
    Small cell lung cancer in never-smokers.
    Eur Respir J. 2015 Dec 23. pii: ERJ-01524-2015. doi: 10.1183/13993003.01524-2015
    PubMed     Text format     Abstract available


  28. REMON J, Gorham J, Besse B, Sculier JP, et al
    Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients?
    Eur Respir J. 2015;46:1548-50.
    PubMed     Text format    


  29. CHAPUT N, Marabelle A
    Foxp3+ cells are running the show in patients with surgically resected nonsmall cell lung cancer.
    Eur Respir J. 2015;46:1541-3.
    PubMed     Text format    


    November 2015
  30. O'CALLAGHAN DS, Rexhepaj E, Gately K, Coate L, et al
    Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
    Eur Respir J. 2015 Nov 5. pii: ERJ-00176-2014. doi: 10.1183/13993003.00176-2014.
    PubMed     Text format     Abstract available


  31. NILSSEN Y, Strand TE, Fjellbirkeland L, Bartnes K, et al
    Lung cancer survival in Norway, 1997-2011: from nihilism to optimism.
    Eur Respir J. 2015 Nov 5. pii: ERJ-00650-2015. doi: 10.1183/13993003.00650-2015.
    PubMed     Text format     Abstract available


  32. KAUCZOR HU, Bonomo L, Gaga M, Nackaerts K, et al
    Lung cancer screening white paper: a slippery step forward?
    Eur Respir J. 2015;46:1521-2.
    PubMed     Text format    


  33. RUANO-RAVINA A, Provencio-Pulla M, Fernandez-Villar A
    Lung cancer screening white paper: a slippery step forward?
    Eur Respir J. 2015;46:1519-20.
    PubMed     Text format    


  34. MEERT AP, Cadranel J
    Targeted therapy for lung cancer.
    Eur Respir J. 2015;46:1239-41.
    PubMed     Text format    


    October 2015
  35. TISSOT C, Toffart AC, Villar S, Souquet PJ, et al
    Circulating free DNA concentration is an independent prognostic biomarker in lung cancer.
    Eur Respir J. 2015 Oct 22. pii: ERJ-00676-2015. doi: 10.1183/13993003.00676-2015
    PubMed     Text format     Abstract available


    September 2015
  36. PAESMANS M, Garcia C, Wong CO, Patz EF Jr, et al
    Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.
    Eur Respir J. 2015 Sep 24. pii: ERJ-00099-2015. doi: 10.1183/13993003.00099-2015
    PubMed     Text format     Abstract available


  37. NAVARRO-TORNE A, Vidal M, Trzaska DK, Passante L, et al
    Chronic respiratory diseases and lung cancer research: a perspective from the European Union.
    Eur Respir J. 2015 Sep 24. pii: ERJ-00395-2015. doi: 10.1183/13993003.00395-2015
    PubMed     Text format    


    August 2015
  38. MORGANT MC, Pages PB, Orsini B, Falcoz PE, et al
    Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study.
    Eur Respir J. 2015 Aug 6. pii: ERJ-00354-2015. doi: 10.1183/13993003.00354-2015.
    PubMed     Text format     Abstract available


    July 2015
  39. BERGHMANS T, Meert AP, Quoix E
    Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutations.
    Eur Respir J. 2015;46:19-21.
    PubMed     Text format    


    June 2015
  40. VILMANN P, Clementsen PF, Colella S, Siemsen M, et al
    Combined endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer.
    Eur Respir J. 2015 Jun 1. pii: ERJ-00645-2015.
    PubMed     Text format    


  41. IZUMO T, Sasada S, Chavez C, Matsumoto Y, et al
    Radial endobronchial ultrasound images for ground-glass opacity pulmonary lesions.
    Eur Respir J. 2015;45:1661-8.
    PubMed     Text format     Abstract available


    May 2015
  42. STAMATIS G
    Staging of lung cancer: the role of noninvasive, minimally invasive and invasive techniques.
    Eur Respir J. 2015 May 14. pii: ERJ-01267-2014.
    PubMed     Text format     Abstract available


    March 2015
  43. INFANTE M
    A conservative approach for subsolid lung nodules: is it safe enough?
    Eur Respir J. 2015;45:592-5.
    PubMed     Text format    


  44. MEINERS S, Eickelberg O, Konigshoff M
    Hallmarks of the ageing lung.
    Eur Respir J. 2015;45:807-27.
    PubMed     Text format     Abstract available


    January 2015
  45. GERSHON AS, Mecredy GC, Guan J, Victor JC, et al
    Quantifying comorbidity in individuals with COPD: a population study.
    Eur Respir J. 2015;45:51-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: